Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.

Karaca, BBozkurt, EAtmaca, RSurmeli, ZPinar, ASanil, UAUslu, R2024-07-182024-07-180732-183X1527-7755http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6444EnglishEffect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.Meeting Abstract